Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Bristol-Myers Squibb Increases Dividend Payout, Continues Long-Standing Streak

December 18, 2024
Bristol-Myers Squibb Company (NYSE: BMY) has announced a larger dividend payment for shareholders compared to last year. With a significant increase to $0.62 per share, the pharmaceutical giant aims to reward its investors while maintaining a strong financial position. This move marks the 16th consecutive annual dividend increase and extends the company's impressive 93-year dividend streak. Bristol-Myers Squibb's commitment to consistent dividend growth showcases its stability and investor-friendly approach.

The decision to raise dividends comes as Bristol-Myers Squibb continues to deliver positive results in the market. Its robust product portfolio and innovative pipeline have contributed to strong financial performance and steady revenue growth. With a focus on developing breakthrough therapies and improving patient outcomes, the company remains an industry leader.

Investors looking to capitalize on the positive momentum of Bristol-Myers Squibb may consider seeking advice from professionals at Stocks Prognosis. With their expertise in analyzing stock movements and market trends, Stocks Prognosis can provide valuable insights and recommendations for investors.

The increased dividend payout reaffirms Bristol-Myers Squibb's commitment to creating long-term value for shareholders and demonstrates confidence in its future prospects. As the company strives to make a positive impact on global healthcare, it remains a promising investment option for both income and growth-focused investors.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

Bristol-Myers Squibb's focus on developing breakthrough therapies sets it apart from its competitors. I'm excited to see what the future holds
— from RyanKing at 12-22-2024 00:38
I've always trusted Bristol-Myers Squibb as a reliable investment option. This dividend increase just confirms my decision
— from NoraJenkins at 12-21-2024 11:53
I've been considering investing in the pharmaceutical industry and this announcement definitely makes Bristol-Myers Squibb more attractive
— from CarterPatterson at 12-21-2024 04:56
I'm not convinced that this dividend increase is significant enough to make a difference for investors
— from InvestorIan at 12-21-2024 00:20
As a long-time investor in Bristol-Myers Squibb, I'm delighted with the consistent dividend growth. It's a testament to their strong financial position
— from CharlesGrant at 12-20-2024 20:11
I'm glad to see that Bristol-Myers Squibb is rewarding its shareholders and showing confidence in its future
— from InvestorIan at 12-20-2024 09:01
I'm not sure if this is sustainable in the long run. What if their financial performance declines in the future?
— from PennyParker at 12-20-2024 08:28
Great news! I have invested in Bristol-Myers Squibb and this increase in dividend payment is a pleasant surprise
— from RyanKing at 12-19-2024 21:10
This news just reinforces my belief in Bristol-Myers Squibb's stability and commitment to shareholder value
— from AvaTurner at 12-19-2024 02:23
I'm skeptical about investing in the pharmaceutical industry. It seems risky with all the regulatory challenges
— from StockSamantha at 12-18-2024 13:12
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....



Related news

ABBVNovember 26, 2024AbbVie Inc. Executes Impressive Performance at Citis 2024 Global Healthcare Conference  ~1 min.

AbbVie Inc., a leading pharmaceutical company, recently showcased its strong growth potential and innovative product portfolio at the Citis 2024 Global Healthcare Conference....

BMYJanuary 9, 2025Bristol-Myers Squibb Announces Breakthrough in Cancer Treatment Research  ~2 min.

Bristol-Myers Squibb, a leading pharmaceutical company, has made a major breakthrough in cancer treatment research....

GSKJanuary 11, 2025Exciting Developments for GSK plc: Breakthrough Therapy Designation Granted for ADC  ~2 min.

GSK plc, a leading pharmaceutical company, has achieved a significant milestone in its journey towards developing breakthrough treatments....

BMYJanuary 4, 2025Bristol-Myers Squibb Company to Expand its Healthcare Offerings at J.P. Morgan Conference  ~1 min.

Bristol-Myers Squibb Company (BMY) is set to present at J.P. Morgan's 43rd Annual Healthcare Conference, showcasing its latest advancements and achievements in the pharmaceutical industry....

MRKJanuary 2, 2025Is Merck & Co. Inc. the Best Pharma Dividend Stock to Buy In 2024?  ~2 min.

Merck & Co. Inc. (MRK) is making waves in the pharmaceutical industry with its impressive track record and commitment to innovation....